Skip to content

Application of blood biomarkers in diagnosis, treatment and prognosis of chronic obstructive pulmonary disease

Application of blood biomarkers in diagnosis, treatment and prognosis of chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061910
Enrollment
Unknown
Registered
2022-07-11
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

Group 1 :
Group 2:
Group 3:

Sponsors

Chongqing Tongliang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age: 40-75 years old; 2. At least 10 years of smoking history; 3. FEV1/FVC ratio = 80%); GOLD2 grade 2 (50% <= FEV1% PRED < 80%); GOLD3 grade 3 (30% <= FEV1% PRED < 50%); GOLD4 grade 4 (fev1% pred < 30%).

Exclusion criteria

Exclusion criteria: 1. Bronchiectasis, bronchial asthma, tuberculosis, lung cancer, lung mass, tuberculous pleurisy, thoracic deformity, pulmonary interstitial fibrosis and other respiratory diseases; 2. Suffering from coronary heart disease, diabetes, nervous system disease, autoimmune disease; 3. History of chest trauma and/or surgery; 4. Failure of liver function, kidney function, heart function and other diseases or malignant tumor diseases; 5. History of mental illness, history of alcohol or drug abuse.

Design outcomes

Primary

MeasureTime frame
C-reactive protein;fibrinogen;pulmonary surface active protein-D;Clara cell protein;brain natriuretic peptide ;soluble receptors for advanced glycation end products;eosinophils;

Countries

China

Contacts

Public ContactXin Zhang

Chongqing Tongliang People's Hospital

474800125@qq.com+86 17708352728

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026